Animal Models for the Development of Cancer Immunotherapy (eBook)
320 Seiten
John Wiley & Sons (Verlag)
978-1-119-53531-7 (ISBN)
Provides readers with a clear understanding of the value and challenges of using common and emerging preclinical models in cancer immunotherapy research and development.
Animal models are essential tools for studying a range of issues in preclinical and clinical research on therapies targeting cancerous tumors. As clinical trials of advances in cancer immunotherapy are predicted to outpace preclinical research in the near future, there remains an urgent need to develop better animal models for preclinical evaluation of novel modulators. Animal Models for the Development of Cancer Immunotherapy provides a detailed overview of different preclinical model systems for development of novel cancer immunotherapies while highlighting how key aspects of individual models translate into clinical findings.
Covering the introduction, development, and therapeutic applications of animal models for cancer immunotherapy, this comprehensive volume helps pharmacologists identify suitable animal models, design pharmacological or translational studies, and advance their mechanistic understanding of therapeutic agents, and increase the possibility of success for novel immunotherapies in clinical settings. Chapters written by prominent leaders in the field address specific models that evaluate immuno-oncology drugs are supported by in-depth case studies and extensive references throughout.
* Emphasizes the importance of modeling tumor metastasis in preclinical models for efficient translation of findings into the clinic
* Explores recently discovered mechanisms of resistance and their preclinical modeling
* Highlights the unique characteristics and features of autologous and allogeneic approaches for humanization of mouse models
* Reviews development of bone marrow-liver-thymus (BLT) immune humanized mice and emerging alternative models such as genetically engineered mouse models (GEMM)
* Discusses alternative animal models for cancer research such as severe combined immunodeficiency (SCID) pigs
Animal Models for the Development of Cancer Immunotherapy is an essential resource for scientists and researchers in the pharmaceutical and biotechnology industries, medicinal chemists and biochemists, cell and molecular biologists, pharmacologists, immunologists, and clinicians.
Seng-Lai Tan, PhD, is Chief Scientific Officer at Immunitas Therapeutics. He has more than 20 years of drug discovery and development experience in both small and large molecule therapeutic modalities, including multi-specific antibodies and stapled peptides. He is former Head of Immunology at Marengo (Elstar) Therapeutics and Forma Therapeutics, and has held leadership positions at EMD Serono Research & Development Institute and Roche.
Table of Content
Introduction
Kannan Karupiah, Mithun Khattar
1. Transplantable Syngeneic Tumor Models
Richard Woessner, Simon Dovedi, Robert Wilkinson
2. Genetically Engineered Mouse Models (GEMM) in Cancer Immunotherapy R&D
Zhao Chen
3. Mouse Tumor Homografts Recapitulate Human Molecular Pathogenesis
Rajendra Kumari, Davy Ouyang, Henry Li.
4. Modeling Resistance to Immune Checkpoint Blockade
Michael Quigley, Matthew J. Meyer and Kanstantsin Katlinski
5. Orthotopic Mouse Models of Colorectal Cancer and Imaging Techniques
Ce Yuan, Xianda Zhao, Dechen Wangmo, Duha Alshareef, Subbaya Subramanian
6. Preclinical Osteoimmuno-oncology Models to Study Effects of Immunotherapies on Bone Metastasis
Tiina E. Kähkönen, Jussi M. Halleen, Jenni Bernoulli
7.Humanized mouse models for cancer immunotherapy: a focus on human PBMC and HSPC reconstitution
Zhuo Li, Xiao Yang, Xiaomin Song
8. Bone Marrow-Liver-Thymus (BLT) Humanized Mice as a Tool to Assess Checkpoint Inhibitor Adverse Events
Kenrick M. Semple, Alan D. Knapton and Kristina E. Howard
9. Development of Swine Models for Cancer Research: SCID Pigs and Other Emerging Pig Models
Adeline N Boettcher and Christopher K Tuggle
Index
Erscheint lt. Verlag | 8.8.2022 |
---|---|
Sprache | englisch |
Themenwelt | Naturwissenschaften ► Chemie |
Schlagworte | Biowissenschaften • Cell & Molecular Biology • Chemie • Chemistry • Drug Discovery & Development • Immunotherapie • Life Sciences • Medical Science • Medizin • Oncology & Radiotherapy • Onkologie • Onkologie u. Strahlentherapie • Tiermodell • Wirkstoffforschung • Wirkstoffforschung u. -entwicklung • Zell- u. Molekularbiologie |
ISBN-10 | 1-119-53531-X / 111953531X |
ISBN-13 | 978-1-119-53531-7 / 9781119535317 |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |
Größe: 14,3 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich